Levetiracetam

Levetiracetam (INN) ( /lɛvɨtɪˈræsɨtæm/) is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam. Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. Since November 2008 the drug has been available as a generic brand in the United States. Levetiracetam has been approved in the European Union ... More
top ↑

Chemical Compound

Average Molar Mass:

  • 170.209 g/mol

Solubility:

Solvent Solubility
top ↑

Facts from the Community

From the BioVenturist base

Indication or disease:

Disease Phase of development
View entire collection »

Technology involved:

Sales:

Amount Currency Year Area
  • 761,000,000
  • 2006
  • 1,026,000,000
  • 2007
View entire collection »

Developed by:

Brand Names:

  • Keppra

Stage of development:

top ↑

Similar topics in Freebase

  • Pregabalin

    Pregabalin

    Pregabalin (INN) ( /prɨˈɡæbəlɨn/) is an anticonvulsant drug used for neuropathic pain and as an adjunct therapy for partial seizures with or without secondary generalization in adults. It has also been found effective for generalized anxiety disorder and is (as of 2007) approved for this use in the...
  • Moexipril

    Moexipril

    Moexipril hydrochloride is a potent orally active non-sulfhydryl angiotensin converting enzyme inhibitor (ACE) which is used for the treatment of hypertension and congestive heart failure. Moexipril can be administered alone or together with other antihypertensives or diuretics. It works by...
  • Deponit

  • Gabapentin

    A synthetic analogue of the neurotransmitter gamma-aminobutyric acid with anticonvulsant activity. Although its exact mechanism of action is unknown, gabapentin appears to inhibit excitatory neuron activity. This agent also exhibits analgesic properties. (NCI04)
  • Atmadisc

  • Lacosamide

    Lacosamide (INN, formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. The U.S. Food and Drug Administration accepted UCB's New Drug Application for lacosamide as of...

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!